Cold Genesys' Series A Round

Cold Genesys raised a round of funding on July 30, 2014. Investors include Ally Bridge Group.

Cold Genesys is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop …

Articles about Cold Genesys' Series A Round: